Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

Clinical trial NCT01175109 · UNKNOWN

Trial details

NCT number

NCT01175109

Sponsor

Deric M Park MD

Status

UNKNOWN

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-10-01

Primary completion

2013-12-01

Enrollment

36

View on ClinicalTrials.gov